ISMPP West 2021 – All Hands on Deck: Opportunities for Connectivity, Transparency, and Inclusivity
ISMPP West 2021 is a LIVE IN-PERSON meeting on October 21-22, 2021, in Irvine, CA, plus a VIRTUAL Encore Event on October 28, 2021! Register now!
Is abstract peer review affected by institutional and geographical bias?
Research from higher-status institutions and countries is postulated to receive more favourable peer review. A recent article suggests this may not be the case.
What are the potential applications of social media and altmetrics in the pharmaceutical industry?
How can pharma unlock the potential of social media? A recent article from EMWA’s Medical Writing journal discusses potential applications.
WHO and ICMRA announce a joint statement on data transparency and integrity
Read about their call to action for the pharmaceutical industry to increase sharing of clinical trial data.
[PODCAST] Successfully navigating the changing medical conference landscape: part 2
David Barrett continues a discussion with Rob Matheis on how medical congresses can deliver value and opportunities for everyone.
How can the healthcare industry embrace the rise of social media video content?
Creators of Industry Voice share tips on how to leverage video content to generate discussion among experts, engage viewers, and build brand value.
New CONSORT extension for trials using cohorts and routinely collected data: CONSORT-ROUTINE
Find out what’s in the new CONSORT-ROUTINE checklist for randomised controlled trials using cohorts and routinely collected data.
Why loss of confidence in previously published findings does not necessarily lead to self-correction of the scientific record
A new study looks at why researchers may question their past conclusions and how likely they are to disclose this publicly.
The ISMPP authorship algorithm: standardising the application of the ICMJE authorship criteria
Avishek Pal discusses the development and launch of the ISMPP Authorship Algorithm.
[PODCAST] Successfully navigating the changing medical conference landscape: part 1
How are medical societies innovating in the face of a changing medical conference landscape? David Barrett (CEO of the American Society of Gene & Cell Therapy) spoke with Rob Matheis to explain.
How to combat health misinformation: insights from a communication and human behaviour expert
Read Brian Southwell’s perspective on what can be done to prevent misinformation and build public trust in science.
[VIDEO] Medical Society Conferences: What we learnt in 2020, what might happen in 2021
Len Starnes discusses how medical societies have integrated digital approaches into their conferences.
Detectives are on the hunt for fake research papers: Nature analysis investigates the paper mill problem
Nature analyses the ongoing battle publishers are facing against paper mills and what editors are doing to identify these fake articles.
Open access publishing seeks to improve equity, but article processing charges may have the opposite effect
A recent study found that authors with certain characteristics are more likely to publish open access, potentially leading to bias.
Patients in Publications online training resource now available
Find out more about what the open access training modules cover.
[PODCAST] Innovation in medical communications: focus on the how
Listen to Jenny Ghith discuss innovative forms of digital communication.